Models
THEMIS MEDICARE LTD.THEMISMEDPharmaceuticals & Biotechnology
₹-8per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model₹(8)implied FY26 P/E (1.8)× · EV/EBITDA (54.8)×
Against CMP ₹124.00−106.1%close of 2026-09-20
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3130%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.
Where the methods land · ₹ per share · the dashed line is the CMP
DCF, rate ±1 · growth ±1your model across the sensitivity grid
₹(8)₹(7)
52-week rangetraded range, a fact not a value
₹65₹148
From enterprise to equity · ₹ crore
| PV of FY27–FY31 free cash flow | 18 |
| PV of terminal value | 8 |
| Enterprise value | 26 |
| less net debt | (96) |
| less non-controlling interest | 0 |
| add non-operating investments | 0 |
| Equity value | (70) |
| ÷ 9.21 crore shares | ₹(8) |
Free cash flow, filed and modelled · ₹ '000 crore
Filed, cash from operations − capexModelled free cash flow to firm
Sensitivity · ₹ per share
Down Across| WACC ↓terminal growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|---|---|---|---|---|
| 10.00% | (8) | (7) | (7) | (7) | (7) |
| 10.50% | (8) | (8) | (8) | (7) | (7) |
| 11.00% | (8) | (8) | (8) | (8) | (7) |
| 11.50% | (8) | (8) | (8) | (8) | (8) |
| 12.00% | (8) | (8) | (8) | (8) | (8) |
The outlined cell is your model. Green figures sit above the CMP of ₹124.00; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.
Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together
| 10th · 50th · 90th percentile, ₹ per share | (8) · (8) · (7) |
| Draws below the CMP | 100% |
| Rank correlation with discount rate | −1.00 |
| Rank correlation with revenue growth | +0.01 |
| Rank correlation with ebitda margin | +0.01 |
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.
Projected cash flow to the firm · ₹ crore
History Forward| ₹ crore | FY23 | FY24 | FY25 | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 354 | 382 | 406 | 342 | 325 | 309 | 293 | 279 | 265 |
| growth % | (10.2) | 7.7 | 6.2 | (15.6) | (5.0) | (5.0) | (5.0) | (5.0) | (5.0) |
| EBITDA | 67 | 52 | 49 | (0) | (0) | (0) | (0) | (0) | (0) |
| margin % | 19.0 | 13.5 | 12.1 | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) |
| less depreciation | (10) | (12) | (10) | (10) | (10) | (9) | (9) | (8) | (8) |
| EBIT | 57 | 39 | 39 | (11) | (10) | (10) | (9) | (9) | (8) |
| less tax on EBIT | 3 | 3 | 2 | 2 | 2 | 2 | |||
| NOPAT | (8) | (8) | (7) | (7) | (6) | (6) | |||
| add depreciation | 10 | 12 | 10 | 10 | 10 | 9 | 9 | 8 | 8 |
| less capex | (29) | (18) | (15) | (5) | (5) | (6) | (7) | (9) | (10) |
| less working-capital build | — | 10 | 10 | 9 | 9 | 8 | |||
| Free cash flow to firm | (13) | (4) | 19 | — | 8 | 6 | 4 | 2 | 1 |
| Discount factor | 0.949 | 0.855 | 0.770 | 0.694 | 0.625 | ||||
| Present value | 8 | 5 | 3 | 2 | 0 |
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.
The three statements, projected · ₹ crore · debt held at 100, dividends at 100% of profit
| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| EBIT | (11) | (10) | (10) | (9) | (9) | (8) |
| Interest at 11.7% on debt | (12) | (12) | (12) | (12) | (12) | |
| Profit before tax | (22) | (21) | (21) | (20) | (20) | |
| Profit after tax | 1 | (16) | (16) | (16) | (15) | (15) |
| Dividends | (5) | 0 | 0 | 0 | 0 | 0 |
| Balance sheet, year end | ||||||
| Cash | 5 | 4 | 1 | (4) | (10) | (18) |
| Working capital | 208 | 198 | 188 | 179 | 170 | 161 |
| Net block and other assets | 385 | 380 | 377 | 375 | 375 | 377 |
| Debt | 100 | 100 | 100 | 100 | 100 | 100 |
| Equity | 399 | 382 | 366 | 351 | 336 | 321 |
| Balance check | 0 | (0) | (0) | (0) | (0) | (0) |
| Cash flow | ||||||
| From operations | 4 | 3 | 3 | 2 | 2 | |
| Investing (capex) | (5) | (6) | (7) | (9) | (10) | |
| Financing (dividends) | 0 | 0 | 0 | 0 | 0 | |
| Net change in cash | (1) | (3) | (5) | (6) | (8) | |
| Free cash flow to equity | (1) | (3) | (5) | (6) | (8) | |
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.
Scenarios side by side · ₹ per share
| Scenario | Template | Growth | Margin | Rate | Terminal | ₹ / share | vs CMP |
|---|---|---|---|---|---|---|---|
| Base · editing | DCF | -5% | -0.1% | 11.00% | 5% | ₹(8) | (106.1)% |
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.